Wednesday, November 11, 2009

Cipla launches drug to treat H1N1 virus

Drug maker Cipla Ltd on Wednesday launched its generic version of Roche's Tamiflu, used in the treatment of the H1N1 swine flu virus, the firm said in a statement.
Cipla's Oseltamivir brand, called Antiflu, will cost 475 rupees for 10 capsules, with 75 ml syrup will be similarly priced.
Cipla's drug is also pre-qualified by the World Health Organisation.


Nitika
PGDM-3rd sem
sec-B

No comments:

Post a Comment